AANEM News Express

AANEM News Express

A Comparison Between IVIg and Plasma Exchange as Preparations Before Thymectomy in Myasthenia Gravis Patients

1/11/2017
 
Alipour-Faz A, Shojaei M, Peyvandi H. A Comparison Between IVIg and Plasma Exchange as Preparations Before Thymectomy in Myasthenia Gravis Patients. Acta Neurol Belg in press.

Submitted by Andrew W. Tarulli, MD, News Science Editorial Board

A small randomized study was conducted in patients with myasthenia gravis who were scheduled to undergo thymectomy. Twenty-four patients were randomized to receive either IVIg 1 g/kg/day x 2 consecutive days or plasma exchange 5 times every other day. Treatments were administered between 10-30 days before the procedure. Post-operative intubation was more common and duration of treatment was longer in patients treated with plasma exchange. There were no differences in duration of hospitalization, length of ICU stay, or post-operative corticosteroid dose between the two groups.


Comment: Although a small study, this report suggests that IVIg and plasma exchange may be comparable preparatory treatments for patients undergoing thymectomy. Traditionally, plasma exchange has been employed as the pre-thymectomy treatment of choice, but the greater convenience of administering IVIg may make it the preferred treatment in anticipation of thymectomy.


About the AANEM News Science Editorial Board

The board helps to highlight significant, timely science news items for AANEM members. It reviews articles in journals and websites, identifies newsworthy items in the field, and writes article summaries.
 


View Related News Stories:

  Practice


Recent AANEM News

Recap: 2019 AMA House of Delegates Annual Meeting

Science News: Efficacy of Botulinum Toxin A for Treating Cramps in Diabetic Neuropathy

Science News: Diagnostic Sensitivity of Electrophysiology and Ultrasonography in Ulnar Neuropathies of Different Severity

Science News: Long-term Effect of Thymectomy Plus Prednisone Versus Prednisone Alone in Patients with Non-thymomatous Myasthenia Gravis: 2-year Extension of the MGTX Randomised Trial

AANEM Returns to Capitol for 6th Annual Hill Day





Advertisement

TPP

Advertisement

ABEM

Advertisement

Find Your Dream Job